Daniel Lang

Daniel Lang

Directeur Financier/CFO chez CASI PHARMACEUTICALS, INC.

Finance
Health Technology
Consumer Services

Profil

Dr. Daniel Lang, MD, is a Chief Financial Officer & Senior Vice President at CASI Pharmaceuticals, Inc. and a President at Axis Therapeutics Ltd.
Dr. Lang was previously employed as a President-Athenex Cell Therapy by Athenex, Inc., a Chief Investment Officer by Victory Capital Management, Inc. (Investment Management), an Analyst by RS Investment Management Co. LLC, a Principal by Farallon Capital Management LLC, a Senior Associate by Brilleon Capital Us, Inc., a Chief Financial Officer by Sapient Medical Group, Pllc, and a Chief Medical Resident by The Mount Sinai Hospital.
He received his undergraduate degree from Cornell University and a doctorate degree from Weill Cornell Medical College.

Postes actifs de Daniel Lang

SociétésPosteDébut
CASI PHARMACEUTICALS, INC. Directeur Financier/CFO 08/07/2024
Axis Therapeutics Ltd. President -
Tous les postes actifs de Daniel Lang

Anciens postes connus de Daniel Lang

SociétésPosteFin
ATHENEXPAR Investor Relations Contact 30/06/2023
Head-Equity Investments 30/08/2019
Analyst-Equity 01/07/2016
Analyst-Equity 31/12/2008
Sapient Medical Group, Pllc Fondateur -
Voir l'expérience en détail de Daniel Lang

Formation de Daniel Lang

Cornell University Undergraduate Degree
Weill Cornell Medical College Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Daniel Lang

Relations

100 +

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
CASI PHARMACEUTICALS, INC.

Health Technology

Entreprise privées8

Finance

Finance

Finance

Health Technology

Health Services

Axis Therapeutics Ltd.

Brilleon Capital Us, Inc.

Sapient Medical Group, Pllc

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Daniel Lang